The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary

Cancer Treat Rep. 1983 Sep;67(9):767-72.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Drug Evaluation, Preclinical / methods*
  • Leukemia, Experimental / drug therapy*
  • Mice
  • National Institutes of Health (U.S.)
  • Research Design
  • United States

Substances

  • Antineoplastic Agents